Robert Zukermann

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski, Bridget‐Anne Kirwan, Stefan D. Anker et al. · The Lancet · 2020 · 723 citations · Full text

Heart Failure, Iron Metabolism, Clinical Nutrition +5

Return to training in the COVID‐19 era: The physiological effects of face masks during exercise

Danny Epstein, Alexander Korytny, Yoni Isenberg et al. · Scandinavian Journal of Medicine and Science in Sports · 2020 · 243 citations · Full text

Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction

Robert Dragu, Shafik Huri, Robert Zukermann et al. · Atherosclerosis · 2006 · 147 citations

Cardiovascular Epidemiology, Cardiovascular Disease, Atherosclerosis +10

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Gregory G. Schwartz, Michael Szarek, Vera Bittner et al. · Diabetes Care · 2021 · 32 citations · Full text